Intercontinental Hotels Group (IHG)
$53.19 2.80 (5.00%)
18:59 EDT IHG Stock Quote Delayed 30 Minutes
Previous Close $53.19
Market Cap 10.14B
PE Ratio -
Volume (Avg. Vol.) 296,900
Day's Range 52.99 - 54.11
52-Week Range 25.39 - 69.12
Dividend & Yield 1.05 (1.98%)
IHG Stock Predictions, Articles, and Intercontinental Hotels Group News
- From InvestorPlace
- From the Web
Here are three hotel stocks to buy in long-term portfolios as the travel industry continues to recover from the pandemic.
Warren Buffett's Berkshire Hathaway has plenty of cash to spend, but what's worth a multibillion-dollar buyout? These seven companies.
IHG (IHG) has been hit with a data breach that reportedly affected 1,200 of its locations around the country, but that figure may be higher.
This week, 4 Hotels Restaurants & Leisure stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
This week, 4 Hotels Restaurants & Leisure stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy").
8 Hotels Restaurants & Leisure stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").
This 10-pack of top stocks for the long haul doesn't include many of the usual retirement picks, but it has the potential to wallop the broader market.
Airbnb still isn't a big threat to standard hotels. And given the hotel industry's optimistic future outlook and low stock prices, now is a good time to invest in hotel stocks.
Services stocks fell on Wall Street on Friday morning, down 1.5%.
Services stocks rose broadly on Wall Street so far on Wednesday, with the sector seeing an overall increase of 1.4%.
The grades of six restaurant and resort stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Services stocks rose broadly on Wall Street so far on Thursday, with the sector seeing an overall increase of 0.1%.
Aimmune Therapeutics rallies on Nestle acquiring, Akcea cheers Ionis acquiring 24% remaining stake, ADiTx Therapeutics and Lipocine among major losers
Gainers: Aimmune Therapeutics (NASDAQ:AIMT) +172%, Akcea Therapeutics (NASDAQ:AKCA) +60%, Pro-Dex (NASDAQ:PDEX) +16%, Kindred Biosciences (NASDAQ:KIN) +14%, Neuronetics (NASDAQ:STIM) +11%.Losers: ADiTx Therapeutics (NASDAQ:ADTX) -11%, Lipocine (NASDAQ:LPCN) -11%, Orchard Therapeutics (NASDAQ:ORTX) -11%, CNS Pharmaceuticals (NASDAQ:CNSP) -9%, Anchiano Therapeutics (NASDAQ:ANCN) -8%.
Gainers: Equillium (NASDAQ:EQ) +220%.electroCore (NASDAQ:ECOR) +175%.WiMi Hologram Cloud (NASDAQ:WIMI) +73%.NovaBay Pharmaceuticals (NYSEMKT:NBY) +40%.Benefytt Technologies (NASDAQ:BFYT) +37%.OncoSec Medical (NASDAQ:ONCS) +37%.Vaxart (NASDAQ:VXRT) +37%.Lizhi (NASDAQ:LIZI) +35%.BiondVax Pharmaceuticals (NASDAQ:BVXV) +31%.Net Element (NASDAQ:NETE) +29%.Losers: Celsion (NASDAQ:CLSN) -63%.Gritstone Oncology (NASDAQ:GRTS) -50%.NextCure (NASDAQ:NXTC) -44%.Anchiano Therapeutics (NASDAQ:ANCN) -32%.Hermitage Offshore Services (NYSE:PSV) -30%.Senmiao Technology (NASDAQ:AIHS) -20%.Arcimoto (NASDAQ:FUV) -19%.Tarena International (NASDAQ:TEDU) -19%.iMedia Brands (NASDAQ:IMBI) -16%.BlueCity Holdings (NASDAQ:BLCT) -16%.
Navellier RatingsPowered by Portfolio Grader